| 1 | 7768965 | Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines. | J Cancer Res Clin Oncol | 1995 |
5 |
| 2 | 7916993 | Preferential primary-response gene expression in promotion-resistant versus promotion-sensitive JB6 cells. | Mol Carcinog | 1994 Oct |
5 |
| 3 | 10669755 | Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. | Mol Cell Biol | 2000 Mar |
1 |
| 4 | 11142097 | Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. | Nutr Cancer | 2000 |
4 |
| 5 | 12470596 | The anti-proliferative gene TIS21 is involved in osteoclast differentiation. | J Biochem Mol Biol | 2002 Nov 30 |
1 |
| 6 | 12839971 | SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. | Cancer Res | 2003 Jul 1 |
2 |
| 7 | 12912967 | Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. | Clin Cancer Res | 2003 Aug 1 |
1 |
| 8 | 14996721 | Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. | Cancer Res | 2004 Mar 1 |
1 |
| 9 | 15015581 | The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway. | Anticancer Res | 2004 Jan-Feb |
2 |
| 10 | 15302583 | TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression. | Exp Cell Res | 2004 Sep 10 |
9 |
| 11 | 15378000 | Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. | Oncogene | 2004 Oct 28 |
2 |
| 12 | 15788397 | Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death. | J Biol Chem | 2005 Jun 3 |
4 |
| 13 | 15870875 | Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells. | Int J Oncol | 2005 Jun |
3 |
| 14 | 16772336 | Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. | J Cell Sci | 2006 Jul 1 |
2 |
| 15 | 16772519 | Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway. | Mol Pharmacol | 2006 Sep |
2 |
| 16 | 16782888 | Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation. | Mol Cell Biol | 2006 Jul |
5 |
| 17 | 17234770 | Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. | Cancer Res | 2007 Jan 15 |
7 |
| 18 | 17475205 | Mechanisms of resistance and adaptation to thapsigargin in androgen-independent prostate cancer PC3 and DU145 cells. | Arch Biochem Biophys | 2007 Aug 1 |
2 |
| 19 | 18188632 | Apoptotic effects of dietary and synthetic sphingolipids in androgen-independent (PC-3) prostate cancer cells. | Lipids | 2008 Feb |
10 |
| 20 | 18196550 | Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2. | Prostate | 2008 May 1 |
1 |
| 21 | 18288394 | Up-regulation of the BTG2 gene in TPA- or RA-treated HL-60 cell lines. | Oncol Rep | 2008 Mar |
9 |
| 22 | 18337750 | The BTG2 protein is a general activator of mRNA deadenylation. | EMBO J | 2008 Apr 9 |
1 |
| 23 | 18729192 | PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances radiosensitivity of prostate carcinoma cells. | Int J Cancer | 2008 Nov 15 |
2 |
| 24 | 18840609 | B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage. | J Biol Chem | 2008 Nov 28 |
26 |
| 25 | 19117054 | Estradiol downregulation of the tumor suppressor gene BTG2 requires estrogen receptor-alpha and the REA corepressor. | Int J Cancer | 2009 Apr 15 |
6 |
| 26 | 19468252 | B-cell translocation gene 2 is over-expressed in peri-infarct neurons after ischaemic stroke. | Pathobiology | 2009 May |
2 |
| 27 | 20082326 | The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells. | J Cell Biochem | 2010 Mar 1 |
1 |
| 28 | 20197462 | p53 Regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways. | Cancer Res | 2010 Mar 15 |
1 |
| 29 | 20558185 | Quinazolines as novel anti-inflammatory histone deacetylase inhibitors. | Mutat Res | 2010 Aug 7 |
1 |
| 30 | 20660502 | Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. | Carcinogenesis | 2010 Sep |
10 |
| 31 | 21172304 | BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity. | Biochem Biophys Res Commun | 2011 Jan 28 |
2 |
| 32 | 21327578 | Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins. | Cell Biochem Biophys | 2011 Sep |
1 |
| 33 | 21339742 | Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib. | Oncogene | 2011 Jul 7 |
2 |
| 34 | 22116304 | L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells. | Am J Physiol Cell Physiol | 2012 Feb 15 |
12 |
| 35 | 22341854 | TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid. | Eur J Cancer | 2012 Oct |
3 |
| 36 | 22392501 | Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells. | Tumour Biol | 2012 Aug |
3 |
| 37 | 22493435 | B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells. | J Biol Chem | 2012 Sep 7 |
1 |
| 38 | 22562501 | BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria. | Clin Exp Metastasis | 2012 Dec |
4 |
| 39 | 23058912 | B-cell translocation gene-2 increases hepatic gluconeogenesis via induction of CREB. | Biochem Biophys Res Commun | 2012 Nov 2 |
14 |
| 40 | 23089312 | TIS21(/BTG2/PC3) accelerates the repair of DNA double strand breaks by enhancing Mre11 methylation and blocking damage signal transfer to the Chk2(T68)-p53(S20) pathway. | DNA Repair (Amst) | 2012 Dec 1 |
3 |
| 41 | 23236473 | The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex. | PLoS One | 2012 |
3 |
| 42 | 23420441 | BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells. | Tumour Biol | 2013 Jun |
2 |
| 43 | 23583382 | Signals regulating necrosis of cardiomyoblast by BTG2(/TIS21/PC3) via activation of GSK3β and opening of mitochondrial permeability transition pore in response to H2O2. | Biochem Biophys Res Commun | 2013 May 10 |
8 |
| 44 | 23857284 | Expression and significance of miRNA-21 and BTG2 in lung cancer. | Tumour Biol | 2013 Dec |
1 |
| 45 | 23876794 | Regulation of Btg2(/TIS21/PC3) expression via reactive oxygen species-protein kinase C-ΝFκΒ pathway under stress conditions. | Cell Signal | 2013 Dec |
8 |
| 46 | 23907596 | TIS21/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells. | J Cancer Res Clin Oncol | 2013 Oct |
8 |
| 47 | 23917204 | TIS21(/BTG2/PC3) inhibits interleukin-6 expression via downregulation of STAT3 pathway. | Cell Signal | 2013 Dec |
2 |
| 48 | 24047462 | B-cell translocation gene 2 mediates crosstalk between PI3K/Akt1 and NFκB pathways which enhances transcription of MnSOD by accelerating IκBα degradation in normal and cancer cells. | Cell Commun Signal | 2013 Sep 18 |
9 |
| 49 | 24586533 | Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells. | PLoS One | 2014 |
1 |
| 50 | 24698107 | Loss of B-cell translocation gene 2 expression in estrogen receptor-positive breast cancer predicts tamoxifen resistance. | Cancer Sci | 2014 Jun |
4 |